ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.911,30
0,07%
S&P 500
5.996,66
1,00%
Dow Jones
43.487,83
0,78%
Euro vs US Dollar
1,03229
0,45%
Bitcoin
108.301,02
5,03%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Caribou Biosciences Inc (CRBU)

  7. Caribou Biosciences Inc (CRBU) News

CRBU

Caribou Biosciences (CRBU)

Caribou Biosciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CRBU
DatumZeitQuelleÜberschriftSymbolFirma
20/01/202511h45PR Newswire (US)Caribou Biosciences, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - CRBUNASDAQ:CRBUCaribou Biosciences Inc
16/01/202511h45PR Newswire (US)CRBU LAWSUIT ALERT: The Gross Law Firm Notifies Caribou Biosciences, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineNASDAQ:CRBUCaribou Biosciences Inc
13/01/202514h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
13/01/202511h45PR Newswire (US)Shareholders of Caribou Biosciences, Inc. Should Contact The Gross Law Firm Before February 24, 2025 to Discuss Your Rights - CRBUNASDAQ:CRBUCaribou Biosciences Inc
13/01/202501h05GlobeNewswire Inc.Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025NASDAQ:CRBUCaribou Biosciences Inc
10/01/202523h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
10/01/202522h55Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
09/01/202511h45PR Newswire (US)Class Action Filed Against Caribou Biosciences, Inc. (CRBU) Seeking Recovery for Investors - Contact The Gross Law FirmNASDAQ:CRBUCaribou Biosciences Inc
07/01/202522h00GlobeNewswire Inc.Caribou Biosciences to Present at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:CRBUCaribou Biosciences Inc
06/01/202511h45PR Newswire (US)The Gross Law Firm Reminds Caribou Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 24, 2025 - CRBUNASDAQ:CRBUCaribou Biosciences Inc
02/01/202518h50PR Newswire (US)Class Action Filed Against Caribou Biosciences, Inc. (CRBU) Seeking Recovery for Investors - Contact The Gross Law FirmNASDAQ:CRBUCaribou Biosciences Inc
02/01/202514h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
02/01/202514h00GlobeNewswire Inc.Caribou Biosciences Appoints Sri Ryali as Chief Financial OfficerNASDAQ:CRBUCaribou Biosciences Inc
06/12/202422h06Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:CRBUCaribou Biosciences Inc
22/11/202422h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
20/11/202422h00GlobeNewswire Inc.Caribou Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:CRBUCaribou Biosciences Inc
15/11/202400h08Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CRBUCaribou Biosciences Inc
06/11/202422h08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRBUCaribou Biosciences Inc
06/11/202422h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
06/11/202422h05GlobeNewswire Inc.Caribou Biosciences Reports Third Quarter 2024 Financial Results and  Provides Business UpdateNASDAQ:CRBUCaribou Biosciences Inc
04/10/202422h02Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
27/09/202422h02Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:CRBUCaribou Biosciences Inc
25/09/202415h00GlobeNewswire Inc.Caribou Biosciences to Present Preclinical Data Supporting Development of CB-010 for Lupus at the American College of Rheumatology Convergence 2024NASDAQ:CRBUCaribou Biosciences Inc
03/09/202422h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
03/09/202414h00GlobeNewswire Inc.Caribou Biosciences Announces the FDA has Granted Fast Track Designations to CB-010 in Refractory SLE and to CB-012 in Relapsed or Refractory AMLNASDAQ:CRBUCaribou Biosciences Inc
26/08/202422h00GlobeNewswire Inc.Caribou Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:CRBUCaribou Biosciences Inc
20/08/202422h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
20/08/202422h05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
12/08/202414h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
12/08/202414h00GlobeNewswire Inc.Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical OfficerNASDAQ:CRBUCaribou Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:CRBU

Kürzlich von Ihnen besucht

COIN
ADAUSD
Cardano
TG
D7G
Nel ASA
COIN
XRPUSD
Ripple
NASDAQ
TSLA
Tesla
TG
432
Arbor Metals
USOTC
DTEGY
Deutsche Telekom (QX)
USOTC
BASFY
BASF (QX)
FX
EURJPY
Euro vs Yen
NASDAQ
AMZN
Amazon.com
CCOM
SILVER
SILVER
AMEX
XLF
Financial Select Sector
TG
LHA
Deutsche Lufthansa
USOTC
BNPQY
BNP Paribas (QX)
TG
NOV
Novo Nordisk
DBI
MDAX
MDAX
TG
BAYN
Bayer
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten